Clinical Trials › NCT07325292
RecruitingPhase 3
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sponsored by Sanofi
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 160
Target enrollment
6
U.S. states
Jan 2026
Start date
Nov 2028
Expected completion
Interventions / Treatments
FrexalimabMRI contrast-enhancing preparations
Conditions studied
Multiple Sclerosis
Where this trial is running (10 sites)
Florida3 sites
Altamonte Springs · Naples · Ormond Beach
Alabama2 sites
Cullman · Homewood
North Carolina2 sites
Charlotte · Raleigh
Arizona1 site
Scottsdale
California1 site
West Hollywood
Tennessee1 site
Knoxville
Participating MS centers on MS Buddy (6)
Charlotte Center for Multiple Sclerosis
Charlotte, NC
Charlotte, NC
Regina Berkovich MD PhD Inc MS Neurology
West Hollywood, CA
West Hollywood, CA
Neurology of Central Florida
Altamonte Springs, FL
Altamonte Springs, FL
Raleigh Neurology Associates, P.A.
Raleigh, NC
Raleigh, NC
Tanner Center for Multiple Sclerosis
Birmingham, AL
Birmingham, AL
Hope Neurology, PLLC
Knoxville, TN
Knoxville, TN
MS centers in Florida
Compare treatment centers near a trial site by center type, providers and trials.
View Florida centersMore Phase 3 trials
Browse all Phase 3 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.